Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
Oncology Today with Dr Neil Love
00:00
M4T/INFORTE: Lurbinectedin in Maintenance
Hossein explains lurbinectedin's mechanism, the INFORTE design, and PFS/OS benefits that led to approval.
Play episode from 10:18
Transcript
